CommentaryPolicy

Pharmacy Benefit Managers, Pharmacies, and Pharmacogenomic Testing: Prescription for Progress?

Science Translational Medicine  11 Aug 2010:
Vol. 2, Issue 44, pp. 44cm22
DOI: 10.1126/scitranslmed.3001067

You are currently viewing the abstract.

View Full Text

Abstract

Few would argue that the ability to match individual patients with the safest and most effective drugs and doses would be a major advance for clinical medicine. But while clinicians have been reluctant to routinely use pharmacogenomic analyses to guide their prescribing practices, pharmacy benefit managers and drugstores are proceeding with major pharmacogenetic initiatives.

Footnotes

  • Citation: E. J. Topol, Pharmacy benefit managers, pharmacies, and pharmacogenomic testing: Prescription for progress? Sci. Transl. Med. 2, 44cm22 (2010).

View Full Text